Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-14
SponsorStanford University
About this trial
This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
Eligibility criteria
Qualifiers
Diagnosed with a mood and/or anxiety disorder
Have proficiency to participate in psychotherapy in English
Scheduled to begin therapy at one of the study sites
RCADS score > 65
Disqualifiers
None
Trial design
Treatments tested in this trial
- Teleo
- Standard Videoconferencing
Treatment groups
156 Participants
are divided into 2 treatment groupsSponsors and collaborators
Stanford University
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
MainSquare Co. (dba 'Teleo')
Collaborator
Source ClinicalTrials.gov